95
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Outcome of Elderly Patients with Aggressive Non-Hodgkin's Lymphoma Refractory to or Relapsing after First-line CHOP or CHOP-like Chemotherapy: A Low Probability of Cure

, , , , , , , & show all
Pages 1391-1394 | Received 26 Nov 2003, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jipan Xie, Aozhou Wu, Laura Liao, Loretta J. Nastoupil, Ella Xiaoyan Du, Ahmed Noman & Lei Chen. (2021) Characteristics and treatment patterns of relapsed/refractory diffuse large B-cell lymphoma in patients receiving ≥3 therapy lines in post-CAR-T era. Current Medical Research and Opinion 37:10, pages 1789-1798.
Read now
Joshua Lukenbill & Brian Hill. (2015) Relapsed/refractory diffuse large B-cell lymphoma: review of the management of transplant-eligible patients. Leukemia & Lymphoma 56:2, pages 293-300.
Read now
Mary J Ninan & Vicki A Morrison. (2009) Therapeutic approaches to non-Hodgkin’s lymphoma in the elderly patient. Expert Review of Hematology 2:2, pages 173-182.
Read now
Ulrich J. M. Mey, Katjana S. Orlopp, Dimitri Flieger, John W. Strehl, Anthony D. Ho, Manfred Hensel, Cordula Bopp, Marcus Gorschlüter, Martin Wilhelm, Josef Birkmann, Ulrich Kaiser, Andreas Neubauer, Axel Florschütz, Christian Rabe, Corinna Hahn, Axel G. Glasmacher & Ingo G. H. Schmidt-Wolf. (2006) Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma. Cancer Investigation 24:6, pages 593-600.
Read now

Articles from other publishers (11)

Shalini Balendran, Constantine Tam & Matthew Ku. (2023) T-Cell Engaging Antibodies in Diffuse Large B Cell Lymphoma—An Update. Journal of Clinical Medicine 12:21, pages 6737.
Crossref
Emily C. Ayers, David Margolis & Daniel J. Landsburg. (2020) Real World Outcomes in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Receiving Palliative Intent Therapies. Clinical Lymphoma Myeloma and Leukemia 20:10, pages 661-667.
Crossref
Christian Gisselbrecht & Eric Van Den Neste. (2018) How I manage patients with relapsed/refractory diffuse large B cell lymphoma. British Journal of Haematology 182:5, pages 633-643.
Crossref
Christian Gisselbrecht & Eric Van Den Neste. (2016) Bridging to Transplant in Diffuse Large B Cell Lymphoma. EMJ Hematology, pages 91-99.
Crossref
Valentina Bozzoli, Maria C. Tisi, Elena Maiolo, Eleonora Alma, Silvia Bellesi, Francesco D'Alo’, Maria T. Voso, Giuseppe Leone & Stefan Hohaus. (2015) Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma . British Journal of Haematology 169:6, pages 787-794.
Crossref
C. Chau, M. Wheater, T. Geldart & S.J. Crabb. (2015) Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients. European Journal of Cancer Care 24:2, pages 155-162.
Crossref
A. Gutiérrez, F. Mestre, G. Pérez-Manga & J. Rodríguez. (2011) Diffuse large B-cell lymphoma in the older. Critical Reviews in Oncology/Hematology 78:1, pages 59-72.
Crossref
László Váróczy, Alpár Dankó, Zsófia Simon, Lajos Gergely, Zsuzsa Ress & Árpád Illés. (2007) Malignant lymphomas in the elderly: A single institute experience highlights future directions. Archives of Gerontology and Geriatrics 45:1, pages 43-53.
Crossref
Catherine Thieblemont & Bertrand Coiffier. (2007) Lymphoma in Older Patients. Journal of Clinical Oncology 25:14, pages 1916-1923.
Crossref
B COIFFIER. 2006. The Lymphomas. The Lymphomas 526 535 .
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:3, pages 135-142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.